OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer
Ning Yi Yap, Nichole Yue Ting Tan, Chia Jie Tan, et al.
Breast Cancer Research and Treatment (2020) Vol. 183, Iss. 3, pp. 683-696
Closed Access | Times Cited: 23

Showing 23 citing articles:

Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
Maryam B. Lustberg, Nicole M. Kuderer, Aakash Desai, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 527-542
Open Access | Times Cited: 106

BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis
Manal T. Usmani, Robert P. Krattli, Sanad M. El-Khatib, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 3, pp. 838-852
Open Access | Times Cited: 22

Crosstalk between the peripheral nervous system and breast cancer influences tumor progression
Jianming Hu, Wuzhen Chen, Lesang Shen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 6, pp. 188828-188828
Closed Access | Times Cited: 31

Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment
Ning Yi Yap, Yi Long Toh, Chia Jie Tan, et al.
Cytokine (2021) Vol. 144, pp. 155556-155556
Open Access | Times Cited: 37

Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients
Ding Quan Ng, Ivy Cheng, Claire Wang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13

The biological intersection between chemotherapy-related cognitive impairment and Alzheimer’s disease
Matthew Torre, Camila A. Zanella, Mel Β. Feany
American Journal Of Pathology (2025)
Open Access

Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: A systematic review of human studies
Ding Quan Ng, Daniella Chan, Parisa Agrawal, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103748-103748
Open Access | Times Cited: 17

Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
Kate Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103822-103822
Open Access | Times Cited: 17

Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicity
Naomi Lomeli, Diana C. Pearre, Maureen T. Cruz, et al.
Experimental Neurology (2024) Vol. 375, pp. 114717-114717
Open Access | Times Cited: 3

Electroacupuncture for the management of symptom clusters in cancer patients and survivors (EAST)
Lifang Xie, Ding Quan Ng, Matthew Heshmatipour, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7

Cancer-related cognitive impairment in racial and ethnic minority groups: a scoping review
Oscar Y. Franco‐Rocha, Kimberly Lewis, Kayla D. Longoria, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 12561-12587
Closed Access | Times Cited: 7

Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram
Marina Šagud, Matea Nikolac Perković, Anja Dvojkovic, et al.
Psychopharmacology (2021) Vol. 238, Iss. 6, pp. 1575-1584
Closed Access | Times Cited: 17

Cancer-Related Cognitive Impairment Associated with APOE rs7412 and BDNF rs6265 in Breast Cancer Survivors
Chao‐Pin Hsiao, T. Goto, Diane Von Ah, et al.
Seminars in Oncology Nursing (2024) Vol. 40, Iss. 5, pp. 151721-151721
Open Access | Times Cited: 1

Neuropsychological Effects of Chemotherapy
Hee‐Ju Kim, Jung Eun Esther Kim, Sun Ok Jung, et al.
Cancer Nursing (2022) Vol. 46, Iss. 3, pp. E159-E168
Closed Access | Times Cited: 7

Effects of vortioxetine on hippocampal-related cognitive impairment induced in rats by androgen deprivation as a model of prostate cancer treatment
Alexandra M. Vaiana, Yidong Chen, Jonathan Gelfond, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3

Feasibility of Cognitive Training to Promote Recovery in Cancer-Related Cognitive Impairment in Adolescent and Young Adult Patients
Megan Gooch, Aditi Mehta, Tami John, et al.
Journal of Adolescent and Young Adult Oncology (2021) Vol. 11, Iss. 3, pp. 290-296
Open Access | Times Cited: 7

The BDNF Val66Met polymorphism serves as a potential marker of body weight in patients with psychiatric disorders
Yinghua Zhang, Xinyue Wei, Wenhao Zhang, et al.
AIMS neuroscience (2024) Vol. 11, Iss. 2, pp. 188-202
Open Access

Perspectives on miRNAs directly targeting BDNF for cancer diagnosis and treatment (Review)
Ziteng Xie, Xiaomeng Xu, Wenbo Cao, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 2
Closed Access | Times Cited: 1

Cisplatin Induces BDNF Downregulation in Middle-Aged Female Rat Model while BDNF Enhancement Attenuates Cisplatin Neurotoxicity
Naomi Lomeli, Diana C. Pearre, Maureen T. Cruz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Biomarkers in the Prediction of Cancer-Related Cognitive Impairment: Implications within Supportive Care
Alexandre Chan, Ding Quan Ng, R Z Yusuf, et al.
Research in Clinical Pharmacy (2023) Vol. 1, Iss. 1, pp. 1-9
Open Access

Page 1

Scroll to top